|
1
|
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|
Cancer Res
|
2003
|
2.07
|
|
2
|
A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.
|
J Neurosci
|
2010
|
1.52
|
|
3
|
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
|
Neuropharmacology
|
2005
|
1.47
|
|
4
|
Mice deficient in nervous system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial learning.
|
J Biol Chem
|
2002
|
1.20
|
|
5
|
Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats.
|
J Biol Rhythms
|
2005
|
1.04
|
|
6
|
Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.
|
Brain Res
|
2004
|
0.91
|
|
7
|
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.
|
J Med Chem
|
2002
|
0.85
|
|
8
|
Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats.
|
Brain Res
|
2010
|
0.81
|
|
9
|
Pharmacological characterization of M-II, the major human metabolite of ramelteon.
|
Pharmacology
|
2014
|
0.76
|
|
10
|
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].
|
Nihon Yakurigaku Zasshi
|
2010
|
0.76
|
|
11
|
Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists.
|
J Med Chem
|
2002
|
0.75
|
|
12
|
[Recent and potential drugs for treatment of insomnia].
|
Nihon Yakurigaku Zasshi
|
2007
|
0.75
|